Sonoma Pharmaceuticals
SNOA
23 hedge funds and large institutions have $1.15M invested in Sonoma Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
10% more funds holding
Funds holding: 21 → 23 (+2)
0% more ownership
Funds ownership: 0.06% → 0.07% (+0%)
37% less capital invested
Capital invested by funds: $1.82M → $1.15M (-$676K)
50% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$91.6K |
| 2 |
Renaissance Technologies
New York
|
+$66.5K |
| 3 |
TSS
Two Sigma Securities
New York
|
+$26.2K |
| 4 |
ARTA
A.R.T. Advisors
New York
|
+$21.8K |
| 5 |
US Bancorp
Minneapolis,
Minnesota
|
+$2.18K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$68K |
| 2 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$13.8K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$9.45K |
| 4 |
BRWA
B. Riley Wealth Advisors
Boca Raton,
Florida
|
-$8.72K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$6.9K |
SNOA Hedge Fund Activity: Q3 2018 in Review
23 of the 4,391 institutional investors tracked by Wall St. Rank reported a position in Sonoma Pharmaceuticals (SNOA) for Q3 2018, worth a combined $1.15M — down 37% from $1.82M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new SNOA positions and 2 closed out — a net gain of 2 holders — while 3 added to existing stakes and 6 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $91.6K. The largest seller was Virtu Financial, exiting entirely with an estimated $68K sold.
- 23 institutional investors held Sonoma Pharmaceuticals (SNOA) as of Q3 2018, up from 21 in Q2 2018.
- Funds reported $1.15M of Sonoma Pharmaceuticals stock for Q3 2018, down 37% quarter-over-quarter.
- 4 funds opened new Sonoma Pharmaceuticals positions in Q3 2018 and 2 closed out, a net change of +2 holders.
- The largest Sonoma Pharmaceuticals buyer in Q3 2018 was Susquehanna International Group, an estimated $91.6K added.
- The largest Sonoma Pharmaceuticals seller in Q3 2018 was Virtu Financial, an estimated $68K sold.
Based on aggregated 13F filings for Q3 2018.